Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
Platform Science v. Omnitracs: Federal Circuit Affirms Patent | PatSnap
Explore in Eureka
Case ID23-1094
FiledOct 2022
ClosedJun 2024
Patent Litigation

Platform Science v. Omnitracs: Federal Circuit Affirms US6925308B2

Platform Science, Inc. successfully defended US6925308B2 — covering auto-fill message fields in communication terminals — against an invalidity challenge by Omnitracs, LLC. The Federal Circuit issued a one-line affirmance on 11 June 2024, closing a 593-day appellate proceeding and leaving the patent fully intact.

Resolution time
593days
593 days from filing to Federal Circuit decision — above median for PTAB appeal resolutions
Patents asserted
1
US6925308B2 — auto-fill message fields in a communication terminal
Outcome
Patent Upheld
Federal Circuit found no reversible error; lower invalidity ruling stands in patentee’s favour
Cost ruling
Patent Upheld
Basis of termination: patent upheld — no costs ruling on public record
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

Federal Circuit closes Omnitracs invalidity challenge with clean affirmance

Platform Science, Inc. filed this Federal Circuit appeal on 27 October 2022 under case number 23-1094, seeking review of a patentability determination involving US6925308B2. The patent, filed under application number US10/074140, protects auto-fill message field technology used in communication terminals — a functionality with clear relevance to fleet management and mobile workforce software platforms.

The underlying proceeding centred on an invalidity or cancellation action brought by Omnitracs, LLC, a direct competitor in the commercial fleet telematics and communications sector. On 11 June 2024, the Federal Circuit issued its order affirming the decision below, meaning the court found no reversible error in the prior tribunal’s conclusion that the patent survives the patentability challenge. US6925308B2 remains valid and enforceable.

The 593-day duration suggests a substantive appellate review rather than a procedural dismissal, consistent with the court having considered briefing and potentially oral argument. The clean, single-word affirmance — without remand — is the strongest possible appellate outcome for Platform Science, foreclosing further challenge on the grounds raised. What drove Omnitracs to pursue this route, and whether parallel district court or IPR proceedings exist, is not determinable from the public appellate record alone.

Case at a glance
Case no.23-1094
CourtCourt of Appeals for the Federal Circuit
JudgeN/A
FiledOctober 27, 2022
ClosedJune 11, 2024
Duration593 days
OutcomePatent Upheld
Verdict causePatentability
BasisPatent Upheld
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Court of Appeals for the Federal Circuit via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Patent Upheld in 593 days

593 days from filing to Federal Circuit decision — above median for PTAB appeal resolutions

Case timeline: Appeal filed OCT 27 2022, AUG–SEP — 593 days total Horizontal timeline showing the three key events in Platform Science, Inc. v Omnitracs, LLC from filing to resolution. Source: PACER, Court of Appeals for the Federal Circuit. OCT 27 2022 Appeal filed Pre-trial proceedings JUN 11 2024 Patent Upheld 593 DAYS TOTAL
Court ruling

Federal Circuit affirms: what the ruling means for both parties

Legal mechanism

What ‘AFFIRMED’ means at the Federal Circuit level

An affirmance by the Federal Circuit means the appellate panel reviewed the lower tribunal’s patentability determination and found no reversible legal error. The original ruling — that US6925308B2 is valid — stands in full. The Federal Circuit does not re-try the case; it reviews for errors of law or clearly erroneous factual findings. A clean affirmance without remand signals the lower decision was both correct and complete.

No reversible error found
Patent holder outcome

Platform Science: patent survives, enforceability strengthened

For Platform Science, the affirmance is the optimal appellate result. US6925308B2 emerges from Federal Circuit scrutiny with its validity confirmed at two levels of review. This appellate endorsement raises the evidentiary bar for any future invalidity challenge on the same grounds. The patent can now be asserted with greater confidence in licensing negotiations or downstream enforcement actions against Omnitracs or third parties operating in the fleet communications space.

Patent fully intact and enforceable
Challenger outcome

Omnitracs exhausts Federal Circuit avenue — options narrow

Omnitracs has exhausted its Federal Circuit appellate route on the arguments raised in this proceeding. Further review would require a petition to the Supreme Court, which grants certiorari in a small fraction of patent cases. Unless new prior art emerges supporting a fresh IPR petition on different grounds, Omnitracs must treat US6925308B2 as a valid patent in its product and licensing strategy going forward.

Appellate options at this level closed
Commercial implications

Affirmed patent raises competitive barriers in fleet comms software

The survival of US6925308B2 through Federal Circuit review signals meaningful IP risk for competitors developing auto-fill or predictive message field features in fleet communication terminals. Companies in the commercial telematics and mobile workforce software space should assess their product architectures against the patent’s claims. Licensing conversations initiated by Platform Science now carry additional credibility given the two-level validity confirmation.

Higher bar for future IPR challenges
Legal analysis based on PACER docket records for case 23-1094 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffPlatform Science, Inc.CompanyFleet and mobile workforce software company — holder of US6925308B2Search in Eureka ↗
DefendantOmnitracs, LLCCompanyOmnitracs, LLC — commercial fleet management and telematics solutions providerSearch in Eureka ↗
Plaintiff counselJason W. WolffAttorneyCounsel for Platform Science, Inc.Search in Eureka ↗
Plaintiff counselJohn C. Phillips Esq.AttorneyCounsel for Platform Science, Inc.Search in Eureka ↗
Plaintiff counselOliver RichardsAttorneyCounsel for Platform Science, Inc.Search in Eureka ↗
Plaintiff law firmFish & Richardson LLPLaw FirmRepresenting Platform Science, Inc.Search in Eureka ↗
Defendant counselAdam R. AlperAttorneyCounsel for Omnitracs, LLCSearch in Eureka ↗
Defendant counselDiva R. HollisAttorneyCounsel for Omnitracs, LLCSearch in Eureka ↗
Defendant counselGianni CutriAttorneyCounsel for Omnitracs, LLCSearch in Eureka ↗
Defendant counselJason M. WilcoxAttorneyCounsel for Omnitracs, LLCSearch in Eureka ↗
Defendant counselJohn C. O’QuinnAttorneyCounsel for Omnitracs, LLCSearch in Eureka ↗
Defendant counselMichael W. De VriesAttorneyCounsel for Omnitracs, LLCSearch in Eureka ↗
Defendant law firmKirkland & Ellis, LLPLaw FirmRepresenting Omnitracs, LLCSearch in Eureka ↗
Presiding judgeJudge N/AJudgeCourt of Appeals for the Federal CircuitSearch in Eureka ↗
Official verdict

Official order — verbatim text

“THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: AFFIRMED.”
Source: PACER Docket, Case 23-1094, Court of Appeals for the Federal Circuit

The Federal Circuit’s order — ‘AFFIRMED’ without qualification or remand — represents the strongest possible appellate outcome for the patent holder. At the Federal Circuit, affirmance on a patentability determination typically means the panel found no reversible error in the lower tribunal’s legal conclusions on invalidity grounds such as anticipation, obviousness, or written description. The absence of a remand instruction confirms the lower decision required no correction, leaving US6925308B2 valid and enforceable on all challenged grounds.

PACER case 23-1094 · Public docket record Explore in Eureka ↗
Patent at issue

US6925308B2 — Auto-fill message fields in communication terminals

Publication No.US6925308B2
Application No.US10/074140
Patent details
ProductAuto-fill message fields in a communication terminal
Cited in actionOctober 27, 2022

US6925308B2, filed under application number US10/074140, protects technology for automatically populating message fields within communication terminals — a capability directly applicable to in-cab driver communication systems and fleet management software platforms. The patent’s technical domain sits at the intersection of mobile communication software and workflow automation, covering the logic by which terminals intelligently pre-fill data fields to reduce operator input burden in real-time communication contexts.

In the commercial fleet telematics sector, auto-fill and predictive input features are foundational to driver messaging systems, dispatch workflows, and regulatory compliance tools such as electronic logging devices. A patent covering this functionality, now affirmed valid at the Federal Circuit, represents meaningful competitive leverage for Platform Science. Any product team building message automation into a fleet communication terminal must assess whether their implementation falls within the scope of US6925308B2’s affirmed claims.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should you run an FTO against US6925308B2?

If your organisation develops, sells, or integrates communication terminal software for commercial fleets — including driver messaging apps, dispatch platforms, ELD-adjacent tools, or in-cab HMI systems with auto-complete or predictive message field features — US6925308B2 is now a higher-priority FTO target following its Federal Circuit affirmance. The patent has withstood an invalidity challenge, meaning it cannot be dismissed as a weak or easily-invalidated right. Product and IP counsel should map current and roadmap features against the patent’s claim set before launch.

PatSnap Eureka’s FTO Search Agent can accelerate this analysis by mapping US6925308B2’s claim elements against your product architecture, surfacing prior art that may still support a design-around argument, and identifying related family members or continuation patents that could extend the risk landscape. Run a claim-by-claim FTO now to quantify exposure and prioritise engineering responses before Platform Science initiates enforcement.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US6925308B2 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar Federal Circuit appeals on fleet telematics and communication software patents

Federal Circuit cases involving communication terminal software and fleet management technology patents — mapped by outcome, technology overlap, and claim type.

🔍
Access 40+ similar cases in PatSnap Eureka
Platform Science, Inc. patent enforcement history, Court of Appeals for the Federal Circuit case history, Platform Science, Inc.’s full IP portfolio, and comparable case analysis
Telematics patent appealsAuto-fill software IP disputesFleet comms invalidity casesFederal Circuit affirmances 2024
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the fleet telematics IP landscape

A Federal Circuit affirmance on communication terminal software patents has direct implications for product teams and IP counsel across the fleet management sector.

Validity confirmed at two levels — licensing leverage shifts to Platform Science

US6925308B2 has now survived a patentability challenge and Federal Circuit review. In licensing contexts, a patent upheld on appeal commands stronger royalty expectations. Any fleet or logistics software provider that has deferred FTO analysis on auto-fill message field technology should prioritise that work now.

Omnitracs must re-examine product exposure without an invalidity shield

With the Federal Circuit avenue exhausted, Omnitracs cannot rely on the same invalidity arguments in future proceedings. The company’s product roadmap for communication terminal features now carries elevated IP risk, and design-around analysis or licensing engagement with Platform Science may be the commercially prudent path forward.

🔒
Full strategic analysis in PatSnap Eureka
Unlock full strategic analysis for fleet telematics software patents following this Federal Circuit affirmance.
Claim-level design-around riskContinuation and family exposureCompetitor portfolio overlap map
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

Platform v Omnitracs — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Assess your exposure to Platform Science’s affirmed fleet comms patent

Run an FTO analysis against US6925308B2 before building or shipping auto-fill message features in fleet communication terminals. PatSnap Eureka surfaces claim boundaries, related family members, and competitive exposure in one workflow.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.